Qin B, Chen H, Gao W, Zhao LB, Zhao MJ, Qin HX, Chen W, Chen L, Yang MX. Efficacy, acceptability, and tolerability of antide- pressant treatments for patients with post-stroke depression: a network meta-analysis. Braz J Med Biol Res. 2018;51:e7218. doi: 10.1590/ 479. Cui M, Huang CY, Wang F. Efficacy and safety of citalopram for the treat- ment of poststroke depression: a meta-analysis. J Stroke Cerebrovasc Dis. 480. Deng L, Qiu S, Yang Y, Wang L, Li Y, Lin J, Wei Q, Yang L, Wang D, Liu M. Efficacy and tolerability of pharmacotherapy for post-stroke de- pression: a network meta-analysis. Oncotarget. 2018;9:23718 23728. 481. Sun Y, Liang Y, Jiao Y, Lin J, Qu H, Xu J, Zhao C. Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis. BMJ Open. 2017;7:e016499. doi: 482. Deng L, Sun X, Qiu S, Xiong Y, Li Y, Wang L, Wei Q, Wang D, Liu M. Interventions for management of post-stroke depression: a bayesian network meta-analysis of 23 randomized controlled trials. Sci Rep. 483. Shen X, Liu M, Cheng Y, Jia C, Pan X, Gou Q, Liu X, Cao H, Zhang L. Repetitive transcranial magnetic stimulation for the treatment of post- stroke depression: a systematic review and meta-analysis of random- ized controlled clinical trials. J Affect Disord. 2017;211:65 74. doi: 484. Xu XM, Zou DZ, Shen LY, Liu Y, Zhou XY, Pu JC, Dong MX, Wei YD. Efficacy and feasibility of antidepressant treatment in patients with post-stroke depression. Medicine (Baltimore). 2016;95:e5349. doi: Powers et al 2019 Guidelines for Management of AIS e417 485. Tan S, Huang X, Ding L, Hong H. Efficacy and safety of citalopram in treating post-stroke depression: a meta-analysis. Eur Neurol. 486. Hackett ML, Anderson CS, House A, Xia J. Interventions for treating depression after stroke. 